|
SFRS2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.178600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.987000E-01 |
| Normal-vs-Stage2 |
9.456000E-01 |
| Normal-vs-Stage3 |
6.318000E-01 |
| Normal-vs-Stage4 |
7.745200E-01 |
| Stage1-vs-Stage2 |
9.703200E-01 |
| Stage1-vs-Stage3 |
6.703600E-01 |
| Stage1-vs-Stage4 |
8.048800E-01 |
| Stage2-vs-Stage3 |
7.350400E-01 |
| Stage2-vs-Stage4 |
8.022200E-01 |
| Stage3-vs-Stage4 |
9.330400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.557600E-01 |
| Normal-vs-AfricanAmerican |
8.272600E-01 |
| Normal-vs-Asian |
5.380400E-01 |
| Caucasian-vs-AfricanAmerican |
8.324200E-01 |
| Caucasian-vs-Asian |
7.327800E-01 |
| AfricanAmerican-vs-Asian |
6.319000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.707600E-01 |
| Normal-vs-Female |
6.205000E-01 |
| Male-vs-Female |
8.156200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.383400E-01 |
| Normal-vs-Extreme_Weight |
8.749000E-01 |
| Normal-vs-Obese |
9.869800E-01 |
| Normal-vs-Extreme_Obese |
3.849800E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.207200E-01 |
| Normal_Weight-vs-Obese |
7.172800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.389400E-01 |
| Extreme_Weight-vs-Obese |
8.319600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.041200E-01 |
| Obese-vs-Extreme_Obese |
4.553400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.161200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.771400E-01 |
| Normal-vs-Age(61-80Yrs) |
9.801600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.775800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.113000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.523600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.895900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.739800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.759540E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.450000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.921360E-01 |
| Normal-VS-Type2 PRCC |
8.291600E-02 |
| Normal-VS-KIRP CIMP |
2.964400E-01 |
| Normal-VS-Unclassified PRCC |
9.209200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.86589999999454E-05 |
| Type1 PRCC-VS-KIRP CIMP |
8.942100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.324200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.808600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.143380E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.529200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.738400E-01 |
| Normal-vs-N1 |
2.252200E-01 |
| Normal-vs-N2 |
6.012200E-01 |
| N0-vs-N1 |
1.158980E-01 |
| N0-vs-N2 |
7.067600E-01 |
| N1-vs-N2 |
3.240200E-01 |
|
|
